<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">HET</journal-id>
<journal-id journal-id-type="hwp">sphet</journal-id>
<journal-id journal-id-type="nlm-ta">Hum Exp Toxicol</journal-id>
<journal-title>Human &amp; Experimental Toxicology</journal-title>
<issn pub-type="ppub">0960-3271</issn>
<issn pub-type="epub">1477-0903</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0960327111422402</article-id>
<article-id pub-id-type="publisher-id">10.1177_0960327111422402</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Synergistic effects of parabens on the induction of <italic>calbindin-D<sub>9k</sub>
</italic> gene expression act via a progesterone receptor-mediated pathway in GH3 cells</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>H</given-names>
</name>
<xref ref-type="aff" rid="aff1-0960327111422402"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nguyen</surname>
<given-names>T-T</given-names>
</name>
<xref ref-type="aff" rid="aff1-0960327111422402"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>An</surname>
<given-names>B-S</given-names>
</name>
<xref ref-type="aff" rid="aff1-0960327111422402"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Choi</surname>
<given-names>K-C</given-names>
</name>
<xref ref-type="aff" rid="aff1-0960327111422402"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Jeung</surname>
<given-names>E-B</given-names>
</name>
<xref ref-type="aff" rid="aff1-0960327111422402"/>
<xref ref-type="corresp" rid="corresp1-0960327111422402"/>
</contrib>
<aff id="aff1-0960327111422402">Laboratory of Veterinary Biochemistry and Molecular Biology, College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk, Republic of Korea</aff>
</contrib-group>
<author-notes>
<corresp id="corresp1-0960327111422402">Eui-Bae Jeung, Laboratory of Veterinary Biochemistry and Molecular Biology, College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk 361-763, Republic of Korea Email: <email>ebjeung@chungbuk.ac.kr</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>2</month>
<year>2012</year>
</pub-date>
<volume>31</volume>
<issue>2</issue>
<fpage>134</fpage>
<lpage>144</lpage>
<permissions>
<copyright-statement>© SAGE Publications 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Although the endocrine-disrupting bioactivity of parabens is weakly estrogenic (parabens are xenoestrogens), their combined synergistic effect is unknown. The aim of this study was to investigate the effects of methyl paraben (MP), ethyl paraben (EP), propyl paraben (PP), isopropyl paraben (IPP), butyl paraben (BP), and isobutyl paraben (IBP), either alone or in combination (MP + EP + PP + BP; PP + IPP; and BP + IBP) on the induction of the estrogenic biomarker gene,<italic> calbindin-D<sub>9k</sub> </italic>(<italic>CaBP-9k</italic>), in rat pituitary lactosomatotrophic GH3 cells. The expression of <italic>CaBP-9k</italic> mRNA and protein was analyzed using real-time PCR and Western blot analysis, respectively. After 24 h of treatment, a significant increase in <italic>CaBP-9k</italic> expression was observed. This was dependent upon the length of the paraben alkyl chains (shortest in MP and longest in IBP). Interestingly, the synergistic effects of these paraben combinations were observed at a dose (10<sup>−5</sup> M) of these parabens, which induced the highest expression of <italic>CaBP-9k</italic> mRNA and protein. To investigate the involvement of estrogen receptors (ERs) and progesterone receptors (PRs), through which parabens exert their effects, the expression levels of <italic>ERα</italic> and <italic>PR-B</italic> were also examined. The expression of <italic>ERα </italic>mRNA and protein fluctuated after paraben treatment in GH3 cells, which was not significant. However, the expression level of <italic>ERα</italic> gene was induced when cotreated with 17β-estradiol (E2) and ICI 182, 780 (estrogen receptor antagonist). The different combinations of parabens induced the expression of the <italic>PR-B</italic> gene, which was abolished by cotreatment with ICI 182,780. The expression patterns of <italic>CaBP-9k</italic> and <italic>PR-B</italic> genes appeared to be similar in response to paraben treatments. This implied that <italic>CaBP-9k</italic> expression in GH3 cells may be induced by parabens via a PR-mediated pathway. Taken together, these results suggest that exposure to multiple parabens at low concentrations may increase their synergistic estrogenic activities in GH3 cells through a PR-mediated pathway.</p>
</abstract>
<kwd-group>
<kwd>parabens</kwd> 
<kwd><italic>cabindin-D<sub>9k</sub></italic></kwd> 
<kwd>gene</kwd> 
<kwd>GH3 cells</kwd> 
<kwd>PR-B involved pathway</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-0960327111422402">
<title>Introduction</title>
<p>Methyl paraben (MP), ethyl paraben (EP), propyl paraben (PP), isopropyl paraben (IPP), butyl paraben (BP), and isobutyl paraben (IBP) are widely used as antimicrobial agents in cosmetics, toiletries, and various drugs because they have relatively low toxicity and long history of safe use.<sup>
<xref ref-type="bibr" rid="bibr1-0960327111422402">1</xref>
</sup> In general, parabens are considered safe, nontoxic, nonirritating, and nonsensitizing to both human and animals.<sup>
<xref ref-type="bibr" rid="bibr2-0960327111422402">2</xref>
</sup> However, several recent studies show that exposure to parabens may disrupt the endocrine system and thus be harmful to animal and human health.<sup>
<xref ref-type="bibr" rid="bibr1-0960327111422402">1</xref>,<xref ref-type="bibr" rid="bibr3-0960327111422402">3</xref>,<xref ref-type="bibr" rid="bibr4-0960327111422402">4</xref>
</sup> As with many other estrogenic compounds that have structures similar to natural and synthetic estrogens, parabens can bind to estrogen receptors (ERs), progesterone receptors (PRs), and pS2 and interfere with the actions of endogenous steroid hormones.<sup>
<xref ref-type="bibr" rid="bibr5-0960327111422402">5</xref>-<xref ref-type="bibr" rid="bibr7-0960327111422402">7</xref>
</sup> The previous studies using MCF-7 human breast cancer cells, ZR-75-1, indicated that parabens act primarily through nuclear hormone receptors.<sup>
<xref ref-type="bibr" rid="bibr5-0960327111422402">5</xref>,<xref ref-type="bibr" rid="bibr6-0960327111422402">6</xref>,<xref ref-type="bibr" rid="bibr8-0960327111422402">8</xref>-<xref ref-type="bibr" rid="bibr10-0960327111422402">10</xref>
</sup> A linear relationship between paraben levels and cell proliferation and ER-binding capacity has been reported.<sup>
<xref ref-type="bibr" rid="bibr11-0960327111422402">11</xref>,<xref ref-type="bibr" rid="bibr12-0960327111422402">12</xref>
</sup> The potent estrogenic activity of parabens is dependent upon the length of their alkyl side chains.<sup>
<xref ref-type="bibr" rid="bibr6-0960327111422402">6</xref>,<xref ref-type="bibr" rid="bibr13-0960327111422402">13</xref>
</sup> Routledge et al. reported that an increase in the size of the alkyl group may enhance paraben-induced transactivation of ERs in vitro.<sup>
<xref ref-type="bibr" rid="bibr14-0960327111422402">14</xref>
</sup> Furthermore, parabens may also increase the risk of estrogen-related end points, including an increased incidence of female breast cancer, interference with male reproductive function, and the development of melanomas.<sup>
<xref ref-type="bibr" rid="bibr15-0960327111422402">15</xref>
</sup>
</p>
<p>The previous studies showed that <italic>calbindin-D<sub>9k</sub> </italic>(<italic>CaBP-9k</italic>), a cytosolic calcium binding protein, is expressed in a variety of mammalian tissues, such as uterus, placenta, intestine, kidney, bone, and pituitary gland.<sup>
<xref ref-type="bibr" rid="bibr16-0960327111422402">16</xref><xref ref-type="bibr" rid="bibr17-0960327111422402"/>–<xref ref-type="bibr" rid="bibr18-0960327111422402">18</xref>
</sup> <italic>CaBP-9k</italic> is involved in interstitial calcium absorption and is regulated at the transcriptional and posttranscriptional levels by 1,25-dihydroxyvitamin (D3). In the rat uterus, <italic>CaBP-9k</italic> expression is strongly regulated by sex steroid hormones. The mechanisms underlying the regulation of <italic>CaBP-9k</italic> expression in uterine myometrium and stromal cells are closely associated with the direct stimulatory effects of 17β-estradiol (E2) and/or the indirect inhibitory effects of progesterone (P4).<sup>
<xref ref-type="bibr" rid="bibr18-0960327111422402">18</xref>
</sup> The GH3 cell line, a well-established pituitary cell line, is sensitive to estrogenic stimulation.<sup>
<xref ref-type="bibr" rid="bibr19-0960327111422402">19</xref>
</sup> Dang et al. showed that a single treatment with environmental compounds such as 4-tert-octylphenyl (OP), 4-nonylphenol (NP), or bisphenol A (BPA) upregulates <italic>CaBP-9k</italic> expression in GH3 cells.<sup>
<xref ref-type="bibr" rid="bibr20-0960327111422402">20</xref>
</sup> Both estrogen-responsive and P4-responsive elements are present in the <italic>CaBP-9k</italic> promoter and mediate the transcriptional regulation of <italic>CaBP-9k</italic> in the rat uterus.<sup>
<xref ref-type="bibr" rid="bibr21-0960327111422402">21</xref>
</sup> A recent study showed that BP enhanced GH3 cell proliferation by acting as a weak thyroid hormone receptor agonist.<sup>
<xref ref-type="bibr" rid="bibr22-0960327111422402">22</xref>
</sup>
</p>
<p>Chemicals are usually present in the environment as mixtures, rather than as single entities, and studies of their effects are limited. One study showed that a combination of different pesticides enhanced the proliferation of MCF-7 cells in the E-Screen in what appeared to be a synergistic manner.<sup>
<xref ref-type="bibr" rid="bibr23-0960327111422402">23</xref>
</sup> Also, the combination of some polychlorinated biphenyls and environmental estrogens induces sex reversal at concentrations that have no effect when the chemicals are used individually.<sup>
<xref ref-type="bibr" rid="bibr24-0960327111422402">24</xref>
</sup> Interaction of estrogenic chemicals with each other leads to produce significant effects, even when combined at concentrations at which, when used alone, they have no observable effects.<sup>
<xref ref-type="bibr" rid="bibr25-0960327111422402">25</xref>
</sup>
</p>
<p>The estrogenic activity of parabens has been evaluated in recent studies.<sup>
<xref ref-type="bibr" rid="bibr7-0960327111422402">7</xref>
</sup> However, the interaction between these chemicals when present at low concentrations is still unknown. Therefore, the aim of this study was to investigate the effects of parabens, both alone and in combination, on GH3 cells by monitoring the expression of the estrogenic biomarker gene, <italic>CaBP-9k</italic>.</p>
</sec>
<sec id="section2-0960327111422402">
<title>Materials and methods</title>
<sec id="section3-0960327111422402">
<title>Chemicals</title>
<p>MP, EP, PP, and E2 were obtained from Sigma Aldrich, Inc. (St Louis, MO, USA). BP was purchased from Sigma Aldrich GmbH (Steinheim, UK). IPP and IBP were obtained from Tokyo Kasei Kogyo Co. Ltd (Tokyo, Japan). The ER antagonist ICI 182,780 was obtained from Tocris (Ellisville, MO, USA). All chemicals were dissolved in dimethyl sulfoxide (DMSO). Rabbit <italic>CaBP-9k</italic> and the goat-anti-rabbit antibodies were provided by Swant (Bellinzona, Switzerland). Anti-ERα and PR-B antibodies and horseradish peroxidase (HRP) conjugated anti-mouse IgG and anti-rabbit antibodies were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA).</p>
</sec>
<sec id="section4-0960327111422402">
<title>Cell culture and treatment</title>
<p>GH3 cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM; Gibco BRL, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (FBS; Gibco BRL, Grand Island, NY, USA), 100 U/ml penicillin and 100 μg/ml streptomycin (Gibco, Grand Island, NY, USA) at 37°C in a humidified atmosphere of 95% O<sub>2</sub> and 5% CO<sub>2</sub>.</p>
<p>For chemical treatment, 2.1 × 10<sup>6</sup> cells were plated in 6-well plates (NUNC, Roskilde, Denmark) and grown until 70–80% confluent. To ensure depletion of steroid hormones and growth factors from the cells, the medium was replaced with starvation media containing phenol red-free DMEM supplemented with 5% charcoal–dextran-stripped FBS and 100 U/ml penicillin–streptomycin, as previously described.<sup>
<xref ref-type="bibr" rid="bibr20-0960327111422402">20</xref>
</sup> The GH3 cells were maintained in starvation media for 7 days before exposure to parabens (either singly or combined) at a concentration 10<sup>−5</sup> M. Each chemical was dissolved in DMSO and added to the starvation media at a final DMSO concentration of 0.1%. E2 (10<sup>−9</sup> M) and DMSO alone (0.1%) were used as positive and negative controls, respectively. The cells were harvested after 24 h and mRNA and protein levels were measured. To identify the mechanism of CaBP-9k induction mediated by these endocrine-disrupting chemical combinations, the cells were treated with different paraben combinations (either two or four compounds mixed at a ratio of 1:1; final concentration 10<sup>−5</sup> M) in the presence or absence of ICI 182,780 (10<sup>−7</sup> M; added 1 h prior to parabens exposure). After 24 h, whole cells were harvested for mRNA and protein analysis. All experiments were performed in triplicate.</p>
</sec>
<sec id="section5-0960327111422402">
<title>RNA extraction and quantitative real-time PCR</title>
<p>Total RNA was extracted using the Trizol reagent (Invitrogen, Carlsbad, CA, USA), according to the manufacturer’s protocol. The concentration of RNA was determined by absorbance at 260 nm. The quality of the RNA was confirmed using visual inspection following electrophoresis on 1% agarose gels. Briefly, total RNA (1 μg) was reverse transcribed into first-strand complementary DNA (cDNA) using moloney murine leukemia virus reverse transcriptase (Invitrogen) and a random primer (a 9-mer, Takara Bio, Otsu, Shiga, Japan). Each cDNA template (1 μl) was analyzed by the addition of 10 μl of 2× SYBR<sup>®</sup> Premix Ex Taq<sup>TM</sup> (TaKaRa Bio. Inc., Otsu, Shiga, Japan) and 10 pM of each primer. Amplification was performed in a 7300 Real-time PCR System (Applied Biosystems, Foster, CA, USA) using the following parameters: denaturation at 95°C for 5 min, 40 cycles of denaturation at 95°C for 30 sec, and annealing and extension at 60°C for 30 sec, and 72°C for 45 sec. The oligonucleotide primer sequences used to amplify <italic>CaBP-9k</italic> (product size, 314 bp) were 5-AAGAG CATTT TTCAA AAATA-3′ (sense) and 5-GTCTC AGAAT TTGCT TTATT-3′ (antisense). The oligonucleotide primer sequences used to amplify the cytochrome c oxidase subunit 1 (<italic>1A</italic>; product size, 293 bp) were 5-CCAGG GTTTG GAATT ATTTC-3′ (sense) and 5-GAAGA TAAAC CCTAA GGCTC-3′ (antisense). The relative expression levels of <italic>CaBP-9k</italic> (normalized to that of <italic>1A</italic>) in each sample were determined using RQ software (Applied Biosystems). All real-time PCR experiments were repeated twice.</p>
</sec>
<sec id="section6-0960327111422402">
<title>Western blot analysis</title>
<p>Protein samples were extracted using pro-prep protein extraction solution (iNtRON Biotechnology, Seoul, South Korea), according to the manufacturer’s instructions. Protein concentrations were determined using a BCA assay (Sigma, St Louis, CA, USA). Cytosolic proteins (50 μg per lane) were resolved in 10% SDS-PAGE gels and transferred onto polyvinylidene fluoride (PVDF) membranes using a trans-blot cell (Bio-Rad, Hercules, CA, USA). The membranes were then blocked for 2 h with phosphate-buffered saline containing 0.1% Tween-20 (PBS-T) and 5% skim milk (Difco<sup>TM</sup>, Sparks, MD, USA). The membrane was then incubated with the indicated primary antibodies diluted in 1% BSA for 3 h (for glyceraldehyde 3-phosphate dehydrogenase [GAPDH] and CaBP-9k) or overnight (for PR-B and ERα) at room temperature. The primary antibodies for CaBP-9k (9 kDa), PR-B (116 kDa), and ERα (66 kDa) were diluted into 1:500 and the anti-GAPDH (38kDa) antibody was diluted into 1:2000. HRP-conjugated anti-mouse IgG (for CaBP-9k and PR-B) and anti-rabbit IgG (for GAPDH and ERα) were diluted 1:3000 in PBS-T/2.5% skim milk. Immunoreactive proteins were visualized by exposing the membranes to an X-ray film. The films were then scanned and the band intensities and optical densities were quantified using Image J software (version 1.52, Wayne Rasband, NIH, Baltimore, MD, USA) after correction by background subtraction and then normalized against GAPDH expression.<sup>
<xref ref-type="bibr" rid="bibr26-0960327111422402">26</xref>
</sup>
</p>
</sec>
<sec id="section7-0960327111422402">
<title>Data analysis</title>
<p>Data were expressed as the mean ± SD and analyzed using one-way analysis of variance (ANOVA) followed by Tukey’s test for multiple comparisons. Analysis was performed using Graph Pad Prism4 for Windows Edition (Graph Pad Software Inc., San Diego, CA, USA). A <italic>p</italic> value of &lt;0.05 was considered statistically significant.</p>
</sec>
</sec>
<sec id="section8-0960327111422402">
<title>Results</title>
<sec id="section9-0960327111422402">
<title>Effects of paraben combinations on the induction of <italic>CaBP-9k</italic> expression</title>
<p>GH3 cells were treated with parabens, either individually or in combination, at a final concentration of 10<sup>−5</sup> M. Samples were collected 24 h after treatment and mRNA and protein levels were analyzed. As shown in <xref ref-type="fig" rid="fig1-0960327111422402">Figure 1A</xref>, exposure of GH3 cells to parabens, either in combination (MP + EP + PP + IPP, PP + IPP, or BP + IBP) or individually (MP, EP, PP, IPP, BP, and IBP) resulted in a significant increase in CaBP-9k transcription compared with vehicle alone. Interestingly, expression of <italic>CaBP-9k</italic> mRNA and protein was highest in cells treated with BP + IBP. E2 (positive control) led to significantly increased levels of <italic>CaBP-9k</italic> gene expression. Similarly, CaBP-9k protein levels were upregulated by both E2 and parabens, with the exception of MP and EP (<xref ref-type="fig" rid="fig1-0960327111422402">Figure 1B</xref>). The difference between CaBP-9k transcription and translation induced by these parabens may be explained by mRNA stability and/or protein accumulation. In addition, the expression of both <italic>CaBP-9k</italic> mRNA and protein increased in parallel with the length and number of branches of the alkyl chains in the individual parabens. A significant increase in the levels of <italic>CaBP-9k</italic> mRNA and protein was observed after treatment with paraben combinations compared with single treatments, suggesting that, when combined, parabens interact in a synergistic manner.</p>
<fig id="fig1-0960327111422402" position="float">
<label>Figure 1.</label>
<caption>
<p>Effects of parabens, either alone or in combination, at a concentration of 10<sup>−5</sup> M on <italic>calbindin-D<sub>9k</sub> </italic>(<italic>CaBP-9k</italic>) mRNA and protein expression in GH3 cells. (A) <italic>CaBP-9k</italic> mRNA expression determined by real-time PCR. (B) CaBP-9k protein expression determined by Western blotting. <italic>CaBP-9k</italic> gene expression was normalized to that of internal control genes (<italic>1A </italic>for mRNA and glyceraldehyde 3-phosphate dehydrogenase [GAPDH] for protein). Data are expressed as the mean ± SD of triplicate experiments. <sup>a</sup>
<italic>p </italic>&lt; 0.05 versus vehicle; <sup>b</sup>
<italic>p </italic>&lt; 0.05 versus parabens (methyl- [MP], ethyl- [EP], propyl- [PP], and butyl paraben [BP]); <sup>c</sup>
<italic>p </italic>&lt; 0.05 versus parabens (propyl- [PP] and isopropyl paraben [IPP]); <sup>d</sup>
<italic>p </italic>&lt; 0.05 versus parabens (butyl- [BP] and isobutyl paraben [IBP]).</p>
</caption>
<graphic alternate-form-of="fig1-0960327111422402" xlink:href="10.1177_0960327111422402-fig1.tif"/>
</fig>
<p>To further understand the mechanisms underlying <italic>CaBP-9k</italic> gene expression induced by the various paraben combinations, the expression of both ERα and PR-B was analyzed at the mRNA and protein level. As illustrated in <xref ref-type="fig" rid="fig2-0960327111422402">Figure 2A</xref> and B, there were fluctuations in the expression levels of <italic>ERα</italic> mRNA and protein. These results highlight a difference between the expression of <italic>CaBP-9k</italic> and <italic>ERα</italic>, suggesting that <italic>CaBP-9k</italic> mRNA and protein expression may not be induced by parabens via an <italic>ERα</italic>-mediated pathway in GH3 cells. Interestingly, <xref ref-type="fig" rid="fig3-0960327111422402">Figure 3A</xref> and B shows that the pattern of paraben-induced <italic>PR-B</italic> expression was similar to that of the <italic>CaBP-9k</italic> gene. PR-B was upregulated by exposure to both E2 and the various paraben combinations. This result indicates that <italic>CaBP-9k</italic> mRNA and protein expression may be induced via a PR-mediated pathway.</p>
<fig id="fig2-0960327111422402" position="float">
<label>Figure 2.</label>
<caption>
<p>Effects of parabens, either alone or in combination, at a concentration of 10<sup>−5</sup> M on the expression of <italic>estrogen receptor α</italic> (<italic>ERα</italic>) mRNA and protein in GH3 cells. (A) <italic>ERα </italic>mRNA expression determined by real-time PCR. (B) ERα protein expression determined by Western blotting. <italic>ERα</italic> gene expression was normalized to that of internal control genes (<italic>1A </italic>for mRNA and glyceraldehyde 3-phosphate dehydrogenase [GAPDH] for protein). Data are expressed as the mean ± SD of triplicate experiments.</p>
</caption>
<graphic alternate-form-of="fig2-0960327111422402" xlink:href="10.1177_0960327111422402-fig2.tif"/>
</fig>
<fig id="fig3-0960327111422402" position="float">
<label>Figure 3.</label>
<caption>
<p>Effects of parabens, either alone or in combination, at a concentration of 10<sup>−5</sup> M on the expression of <italic>progesterone receptor B </italic>(<italic>PR-B</italic>) mRNA and protein in GH3 cells. (A) <italic>PR-B </italic>mRNA expression determined by real-time PCR. (B) PR-B protein expression determined by Western blotting. <italic>PR-B</italic> gene expression was normalized to that of internal control genes (<italic>1A </italic>for mRNA and glyceraldehyde 3-phosphate dehydrogenase [GAPDH] for protein). Data are expressed as the mean ± SD of triplicate experiments. <sup>a</sup>
<italic>p </italic>&lt; 0.05 versus vehicle; <sup>b</sup>
<italic>p </italic>&lt; 0.05 versus parabens (methyl- [MP], ethyl- [EP], propyl- [PP], and butyl paraben [BP]); <sup>c</sup>
<italic>p </italic>&lt; 0.05 versus parabens (propyl- [PP] and isopropyl paraben [IPP]); <sup>d</sup>
<italic>p </italic>&lt; 0.05 versus isobutyl paraben (IBP).</p>
</caption>
<graphic alternate-form-of="fig3-0960327111422402" xlink:href="10.1177_0960327111422402-fig3.tif"/>
</fig>
</sec>
<sec id="section10-0960327111422402">
<title>Effects of ICI 182,780 on paraben-induced <italic>CaBP-9k</italic>
</title>
<p>To identify the steroid hormone receptor pathway involved in transcriptional and translational upregulation of <italic>CaBP-9k</italic> expression by the various paraben combinations, GH3 cells were pretreated with the ER antagonist, ICI 182,780. <italic>CaBP-9k</italic> mRNA and protein levels were then analyzed by real-time PCR and Western blotting, respectively. As seen in <xref ref-type="fig" rid="fig4-0960327111422402">Figure 4A</xref> and B, the induction of <italic>CaBP-9k</italic> mRNA and protein by E2 and the different paraben combinations was completely abolished by cotreatment with ICI 182,780 at a concentration of 10<sup>−7</sup> M.</p>
<fig id="fig4-0960327111422402" position="float">
<label>Figure 4.</label>
<caption>
<p>Effects of the antiestrogen, ICI 182,780, on the <italic>calbindin-D<sub>9k</sub> </italic>(<italic>CaBP-9k</italic>) mRNA and protein expression after treatment with various paraben combinations at 10<sup>−5</sup> M. GH3 cells were pretreated with ICI 182,780 (10<sup>−7</sup> M) for 1 h prior to paraben exposure. (A) <italic>CaBP-9k</italic> mRNA expression determined by real-time PCR. (B) CaBP-9k protein expression determined by Western blotting. <italic>CaBP-9k</italic> gene expression was normalized to that of internal control genes (<italic>1A </italic>for mRNA and glyceraldehyde 3-phosphate dehydrogenase [GAPDH] for protein). Data are expressed as the mean ± SD of triplicate experiments. <sup>a</sup>
<italic>p </italic>&lt; 0.05 versus vehicle; <sup>b</sup>
<italic>p </italic>&lt; 0.05 versus chemical-only treated groups.</p>
</caption>
<graphic alternate-form-of="fig4-0960327111422402" xlink:href="10.1177_0960327111422402-fig4.tif"/>
</fig>
<p>Next, the expression levels of <italic>ERα</italic> and <italic>PR-B</italic> mRNA and protein were analyzed. Although <italic>ERα</italic> mRNA and protein expression levels were not changed after treatments with E2 or paraben combinations, there was a significant increase in <italic>ERα</italic> mRNA and its protein levels, respectively, following treatment with ICI as shown in <xref ref-type="fig" rid="fig5-0960327111422402">Figure 5A</xref> and B. However, the mRNA and protein expression levels of <italic>PR-B</italic> were induced by E2 or paraben combinations, which were completely blocked by ICI treatment as seen in <xref ref-type="fig" rid="fig6-0960327111422402">Figure 6A</xref> and B. This expression pattern appears to be in parallel with that of <italic>CaBP-9k</italic> gene. This result provides further evidence that exposure of GH3 cells to estrogenic parabens specifically upregulates PR levels, suggesting that <italic>CaBP-9k</italic> gene expression may be induced, in part, through PRs in response to various combinations of estrogenic parabens.</p>
<fig id="fig5-0960327111422402" position="float">
<label>Figure 5.</label>
<caption>
<p>Effects of treatment with various paraben combinations (10<sup>−5</sup> M) with/without ICI 182,780 on <italic>estrogen receptor α </italic>(<italic>ERα</italic>) mRNA and protein expression. GH3 cells were pretreated with ICI 182,780 (10<sup>−7</sup> M) for 1 h prior to paraben exposure. (A) <italic>ERα</italic> mRNA expression determined by real-time PCR. (B) ERα protein expression determined by Western blotting. <italic>ERα</italic> gene expression was normalized to that of internal control genes (<italic>1A </italic>for mRNA and glyceraldehyde 3-phosphate dehydrogenase [GAPDH] for protein). Data are expressed as the mean ± SD of triplicate experiments. <sup>a</sup>
<italic>p </italic>&lt; 0.05 versus vehicle; <sup>b</sup>
<italic>p </italic>&lt; 0.05 versus chemical-only treated groups.</p>
</caption>
<graphic alternate-form-of="fig5-0960327111422402" xlink:href="10.1177_0960327111422402-fig5.tif"/>
</fig>
<fig id="fig6-0960327111422402" position="float">
<label>Figure 6.</label>
<caption>
<p>Effects of treatment with various paraben combinations (10<sup>−5</sup> M) with/without ICI 182,780 on <italic>progesterone receptor B </italic>(<italic>PR-B</italic>) mRNA and protein expression. GH3 cells were pretreated with ICI 182,780 (10<sup>−7</sup> M) for 1 h prior to paraben exposure. (A) <italic>PR-B</italic> mRNA expression determined by real-time PCR. (B) PR-B protein expression determined by Western blotting. <italic>PR-B </italic>gene expression was normalized to that of internal control genes (<italic>1A </italic>for mRNA and glyceraldehyde 3-phosphate dehydrogenase [GAPDH] for protein). Data are expressed as the mean ± SD of triplicate experiments. <sup>a</sup>
<italic>p </italic>&lt; 0.05 versus vehicle; <sup>b</sup>
<italic>p </italic>&lt; 0.05 versus chemical-only treated groups.</p>
</caption>
<graphic alternate-form-of="fig6-0960327111422402" xlink:href="10.1177_0960327111422402-fig6.tif"/>
</fig>
</sec>
</sec>
<sec id="section11-0960327111422402">
<title>Discussion</title>
<p>It is well documented that the <italic>CaBP-9k</italic> gene is controlled by sex hormones. The expression of the <italic>CaBP-9k</italic> gene is upregulated by estrogen and downregulated by P4 during the estrous cycle and early pregnancy in the rat uterus.<sup>
<xref ref-type="bibr" rid="bibr27-0960327111422402">27</xref>,<xref ref-type="bibr" rid="bibr28-0960327111422402">28</xref>
</sup> Recently, the estrogenic activity of a panel of structurally related parabens, including MP, EP, PP, IPP, BP, and IBP, were evaluated in the GH3 cell line by monitoring the expression of the estrogenic biomarker gene, <italic>CaBP-9k</italic>. Indeed, several studies show that the <italic>CaBP-9k </italic>gene can be used as a potential biomarker for assessing the ‘estrogenicity’ of environmental compounds.<sup>
<xref ref-type="bibr" rid="bibr29-0960327111422402">29</xref>,<xref ref-type="bibr" rid="bibr30-0960327111422402">30</xref>
</sup> Expression of the <italic>CaBP-9k</italic> gene is regulated by some xenoestrogenic chemicals, such as OP, NP, BPA, genistein, and parabens in many cell types, including immature rat uterus,<sup>
<xref ref-type="bibr" rid="bibr7-0960327111422402">7</xref>,<xref ref-type="bibr" rid="bibr21-0960327111422402">21</xref>,<xref ref-type="bibr" rid="bibr31-0960327111422402">31</xref>
</sup> rodent pituitary gland,<sup>
<xref ref-type="bibr" rid="bibr17-0960327111422402">17</xref>,<xref ref-type="bibr" rid="bibr18-0960327111422402">18</xref>
</sup> and GH3 cells.<sup>
<xref ref-type="bibr" rid="bibr20-0960327111422402">20</xref>
</sup> This suggests that this gene is a useful biomarker for evaluating the ‘estrogenicity’ of environmental estrogen-like compounds.</p>
<p>Previous studies showed that parabens have structural similarities to alkyl phenols and they are, therefore, able to induce weak estrogenic effects both in vitro and in vivo.<sup>
<xref ref-type="bibr" rid="bibr32-0960327111422402">32</xref>
</sup> Because of this bioactivity, parabens are thought to disrupt the development of the male and female reproductive tracts at critical phases during maturation.<sup>
<xref ref-type="bibr" rid="bibr14-0960327111422402">14</xref>,<xref ref-type="bibr" rid="bibr33-0960327111422402">33</xref>,<xref ref-type="bibr" rid="bibr34-0960327111422402">34</xref>
</sup> Parabens are readily absorbed through the skin and gastrointestinal tract, after which they are metabolized via hydrolysis to <italic>p</italic>-hydroxybenzoic acid.<sup>
<xref ref-type="bibr" rid="bibr3-0960327111422402">3</xref>
</sup> The bioactivity of ingested parabens has adverse reproductive effects due to their rapid absorption, metabolism and excretion as urinary conjugates.<sup>
<xref ref-type="bibr" rid="bibr3-0960327111422402">3</xref>,<xref ref-type="bibr" rid="bibr35-0960327111422402">35</xref>
</sup> Moreover, parabens might have achieved full agonist responses at lower concentrations if the assays had been longer in duration.<sup>
<xref ref-type="bibr" rid="bibr15-0960327111422402">15</xref>
</sup> For instance, there were no estrogenic responses to MP, EP, and PP at a dose of 100 mg/kg per body weight/day in a murine uterotrophic assay; however, rat uterine weight increased after a high dose of 600 mg/kg per body weight/day.<sup>
<xref ref-type="bibr" rid="bibr10-0960327111422402">10</xref>,<xref ref-type="bibr" rid="bibr32-0960327111422402">32</xref></sup> The potential ‘estrogenicity’ of parabens has been demonstrated in various cell-based assays, including the MCF-7<sup><xref ref-type="bibr" rid="bibr10-0960327111422402">
10</xref>,<xref ref-type="bibr" rid="bibr36-0960327111422402">36</xref>
</sup> and ZR-75-1 breast cancer cell lines.<sup>
<xref ref-type="bibr" rid="bibr8-0960327111422402">8</xref>,<xref ref-type="bibr" rid="bibr37-0960327111422402">37</xref>
</sup> Parabens bind to the ER, activate genes controlled by these receptors, stimulate cell growth, and increase the immunoreactivity of ERs.<sup>
<xref ref-type="bibr" rid="bibr38-0960327111422402">38</xref>
</sup> A panel comprising MP, EP, <italic>n</italic>-PP, and <italic>n</italic>-BP increased the proliferation rate of MCF-7 breast cancer cells.<sup>
<xref ref-type="bibr" rid="bibr5-0960327111422402">5</xref>
</sup>
</p>
<p>In the present study, we showed that <italic>CaBP-9k</italic> expression in GH3 cells is a useful ‘readout’ for evaluating the estrogenic potential of environmental chemicals such as parabens. The results showed a marked increase in <italic>CaBP-9k</italic> mRNA and protein expression (2.3–3.7-fold and 4.2–8.7-fold, respectively) after treatment with the doses (10<sup>−5</sup> M and 10<sup>−4</sup> M) of long alkyl chain parabens (PP, IPP, BP, and IBP). However, the induction of <italic>CaBP-9k</italic> mRNA and protein expression was weak compared with that induced by the positive control, E2 (10<sup>−9</sup> M; 4.2-fold and 9.8-fold, respectively). Similarly, a weak relative binding affinity (in the order of 0.001% for parabens compared with estrogen) has been reported from in vitro assays using MCF-7, ZR-75-1, HELN, and HELNα and HELNβ (HeLa cells stably transfected with an ERE-driven luciferase plasmid) cell lines, in which E2 was shown to act maximally between 10<sup>−10</sup> M and 10<sup>−8</sup> M and parabens between 10<sup>−5</sup> M and 10<sup>−4</sup> M.<sup>
<xref ref-type="bibr" rid="bibr5-0960327111422402">5</xref>,<xref ref-type="bibr" rid="bibr8-0960327111422402">8</xref>,<xref ref-type="bibr" rid="bibr11-0960327111422402">11</xref>,<xref ref-type="bibr" rid="bibr39-0960327111422402">39</xref>
</sup> We also showed that increased alkyl chain length correlated with increased <italic>CaBP-9k</italic> expression, suggesting that <italic>CaBP-9k</italic> expression in GH3 cells is a sensitive and effective measure of the estrogenic activity of environmental chemicals and their structural relatives.</p>
<p>The present study showed that various combinations of parabens exert a synergistic effect on <italic>CaBP-9k</italic> expression at a dose of 10<sup>−5</sup> M. It was also showed that increasing the length of the alkyl chain of the paraben side group correlates with increased <italic>CaBP-9k</italic> gene expression. Arnold et al. reported the E2 and 17α-estradiol (EE) act synergistically in yeast strains expressing human ERs; this synergistic activity being evident at submaximal concentrations (1 nM) of E2.<sup>
<xref ref-type="bibr" rid="bibr40-0960327111422402">40</xref>
</sup>
</p>
<p>To identify the biological pathways involved in the induction of <italic>CaBP-9k</italic> gene expression in GH3 cells following exposure to various paraben combinations, an antiestrogen (ICI 182,780) was employed to examine the potential involvement of <italic>ER</italic> or <italic>PR</italic> in paraben-induced responses in vitro. <italic>CaBP-9k</italic> mRNA and protein expression were completely abolished in cells co-treated with ICI 182,780. However, <italic>ERα</italic> mRNA and protein levels increased after coexposure to ICI 182,780 compared with exposure to E2, parabens alone, or in combination. However, its mechanism is not known in regard to increased expression of <italic>ERα</italic> mRNA and protein levels by ICI 182,780. In other studies, a significant increase in <italic>ERα</italic> mRNA and protein expression (a minimum of 30% and 20%, respectively) compared with parabens alone was observed. ICI 182,780 binds, inhibits, and promotes the degradation of ERs<sup><xref ref-type="bibr" rid="bibr41-0960327111422402">
41</xref>,<xref ref-type="bibr" rid="bibr42-0960327111422402">42</xref></sup> and decreases the expression of ERα, but not that of ERβ or the androgen receptor (AR), in rats.<sup>
<xref ref-type="bibr" rid="bibr43-0960327111422402">43</xref>
</sup> Moreover, ICI 182,780 reduces ER steady-state levels by increasing the turnover of the protein.<sup>
<xref ref-type="bibr" rid="bibr44-0960327111422402">44</xref>-<xref ref-type="bibr" rid="bibr46-0960327111422402">46</xref>
</sup> In another study, measurement of uterine nuclear ER levels showed a 20% reduction in total ER levels within 0.5 h of ICI 182,780 treatment. ICI also affected ER expression in an in vitro model using mouse TM4 estrogen-responsive cells and dramatically reduced ER levels to 5% of the control value by 4 h.<sup>
<xref ref-type="bibr" rid="bibr45-0960327111422402">45</xref>
</sup> However, ICI 182,780 may affect ER downregulation in a dose-dependent manner. An approximately 70% reduction in ER expression was observed with a single dose (250 mg) of ICI 182,780.<sup>
<xref ref-type="bibr" rid="bibr47-0960327111422402">47</xref>
</sup> In other study, ICI 182,780 mimicked some E2 actions in gene expression in the liver of sea bream by upregulating ERα.<sup>
<xref ref-type="bibr" rid="bibr48-0960327111422402">48</xref>
</sup> In this study, ICI 182,780 does not seem to play a role as an antiestrogen since it did not block the effects of an E2 challenge in GH3 cells, suggesting that the biological activity of parabens may not be involved in an ER-mediated signaling pathway in these cells.</p>
<p>To further demonstrate the potential impact of various paraben combinations on <italic>CaBP-9k</italic> gene expression, <italic>PR-B</italic> levels were analyzed. <italic>PR</italic> is an E2-responsive gene and an indicator of ERα-mediated transcription in the rat uterus.<sup>
<xref ref-type="bibr" rid="bibr49-0960327111422402">49</xref>
</sup> PR expression is induced via an ER-activated protein-1 pathway.<sup>
<xref ref-type="bibr" rid="bibr50-0960327111422402">50</xref>
</sup> In the present study, we found that the patterns of <italic>CaBP-9k</italic> and <italic>PR-B</italic> gene expression in response to paraben treatment were similar and that pretreatment with ICI 182,780 completely attenuated <italic>PR-B</italic> expression. In addition, we also observed downregulated <italic>ERα</italic> expression and upregulated PR levels following paraben exposure in vivo.<sup>
<xref ref-type="bibr" rid="bibr6-0960327111422402">6</xref>,<xref ref-type="bibr" rid="bibr51-0960327111422402">51</xref>
</sup> Previous studies show that ICI 182,780 blocks PR-mediated transcription in the immature rat uterus,<sup><xref ref-type="bibr" rid="bibr7-0960327111422402">
7</xref></sup> and in several cell lines, including HeLa, HepG2, and CV1 (which are considered the best cell lines for determining antiestrogenic activity).<sup>
<xref ref-type="bibr" rid="bibr52-0960327111422402">52</xref>
</sup> In GH3 cells, the luciferase activity of ERE (estrogen response element) sequences was induced by E2 and paraben, which was similar to the enhanced expression of <italic>CaBP-9k</italic> and PR following paraben exposure.<sup>
<xref ref-type="bibr" rid="bibr53-0960327111422402">53</xref>
</sup>
</p>
<p>Taken together, our results indicate that various paraben combinations can increase the expression of <italic>CaBP-9k</italic> mRNA and protein in GH3 cells, and its regulations may affect the steroid hormone receptors. In addition, an estrogenic activity of parabens was blocked by ICI 182,780, an ER antagonist, in GH3 cells. Nevertheless, further research is needed to elucidate the potential endocrine-disrupting activity of parabens and other exogenous combinations and their potential effects on human health.</p>
</sec>
</body>
<back>
<fn-group>
<title>Authors’ note</title>
<fn fn-type="other" id="fn1-0960327111422402">
<p>H Yang and T-T Nguyen equally contributed as first authors.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-0960327111422402">
<p>This work was supported by a grant from the Next-Generation BioGreen 21 Program (No. PJ008323), Rural Development Administration, Republic of Korea.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0960327111422402">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Golden</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gandy</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vollmer</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>A review of the endocrine activity of parabens and implications for potential risks to human health</article-title>. <source>Crit Rev Toxicol</source> <year>2005</year>; <volume>35</volume>: <fpage>435</fpage>–<lpage>458</lpage>.</citation>
</ref>
<ref id="bibr2-0960327111422402">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pugazhendhi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sadler</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Darbre</surname>
<given-names>PD</given-names>
</name>
</person-group>. <article-title>Comparison of the global gene expression profiles produced by methylparaben, n-butylparaben and 17beta-oestradiol in MCF7 human breast cancer cells</article-title>. <source>J Appl Toxicol</source> <year>2007</year>; <volume>27</volume>: <fpage>67</fpage>–<lpage>77</lpage>.</citation>
</ref>
<ref id="bibr3-0960327111422402">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soni</surname>
<given-names>MG</given-names> </name>
<name>
<surname>Burdock</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Greenberg</surname>
<given-names>NA</given-names>
</name>
</person-group>. <article-title>Safety assessment of propyl paraben: a review of the published literature</article-title>. <source>Food Chem Toxicol</source> <year>2001</year>; <volume>39</volume>: <fpage>513</fpage>–<lpage>532</lpage>.</citation>
</ref>
<ref id="bibr4-0960327111422402">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prusakiewicz</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Harville</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ackermann</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Voorman</surname>
<given-names>RL</given-names>
</name>
</person-group>. <article-title>Parabens inhibit human skin estrogen sulfotransferase activity: possible link to paraben estrogenic effects</article-title>. <source>Toxicology</source> <year>2007</year>; <volume>232</volume>: <fpage>248</fpage>–<lpage>256</lpage>.</citation>
</ref>
<ref id="bibr5-0960327111422402">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Byford</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Drew</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Pope</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Sauer</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Darbre</surname>
<given-names>PD</given-names>
</name>
</person-group>. <article-title>Oestrogenic activity of parabens in MCF7 human breast cancer cells</article-title>. <source>J Steroid Biochem Mol Biol</source> <year>2002</year>; <volume>80</volume>: <fpage>49</fpage>–<lpage>60</lpage>.</citation>
</ref>
<ref id="bibr6-0960327111422402">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okubo</surname>
<given-names>T</given-names> </name>
<name>
<surname>Yokoyama</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kano</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kano</surname>
<given-names>I</given-names>
</name>
</person-group>. <article-title>ER-dependent estrogenic activity of parabens assessed by proliferation of human breast cancer MCF-7 cells and expression of ERalpha and PR</article-title>. <source>Food Chem Toxicol</source> <year>2001</year>; <volume>39</volume>: <fpage>1225</fpage>–<lpage>1232</lpage>.</citation>
</ref>
<ref id="bibr7-0960327111422402">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vo</surname>
<given-names>TT</given-names>
</name>
<name>
<surname>Jeung</surname>
<given-names>EB</given-names>
</name>
</person-group>. <article-title>An evaluation of estrogenic activity of parabens using uterine calbindin-D9k gene in an immature rat model</article-title>. <source>Toxicol Sci</source> <year>2009</year>; <volume>112</volume>: <fpage>68</fpage>–<lpage>77</lpage>.</citation>
</ref>
<ref id="bibr8-0960327111422402">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pugazhendhi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Pope</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Darbre</surname>
<given-names>PD</given-names>
</name>
</person-group>. <article-title>Oestrogenic activity of p-hydroxybenzoic acid (common metabolite of paraben esters) and methylparaben in human breast cancer cell lines</article-title>. <source>J Appl Toxicol</source> <year>2005</year>; <volume>25</volume>: <fpage>301</fpage>–<lpage>309</lpage>.</citation>
</ref>
<ref id="bibr9-0960327111422402">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vanparys</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Maras</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lenjou</surname>
<given-names> M</given-names>
</name>
<name>
<surname>Robbens</surname>
<given-names> J</given-names>
</name>
<name>
<surname>Van Bockstaele</surname>
<given-names> D</given-names>
</name>
<name>
<surname>Blust</surname>
<given-names> R</given-names>
</name>
<etal/>
</person-group>. <article-title>Flow cytometric cell cycle analysis allows for rapid screening of estrogenicity in MCF-7 breast cancer cells</article-title>. <source>Toxicol In Vitro</source> <year>2006</year>; <volume>20</volume>: <fpage>1238</fpage>–<lpage>1248</lpage>.</citation>
</ref>
<ref id="bibr10-0960327111422402">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harvey</surname>
<given-names>PW</given-names>
</name>
</person-group>. <article-title>Parabens, oestrogenicity, underarm cosmetics and breast cancer: a perspective on a hypothesis</article-title>. <source>J Appl Toxicol</source> <year>2003</year>; <volume>23</volume>: <fpage>285</fpage>–<lpage>288</lpage>.</citation>
</ref>
<ref id="bibr11-0960327111422402">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gomez</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Pillon</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fenet</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Rosain</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Duchesne</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Nicolas</surname>
<given-names>JC</given-names>
</name>
<etal/>
</person-group>. <article-title>Estrogenic activity of cosmetic components in reporter cell lines: parabens, UV screens, and musks</article-title>. <source>J Toxicol Environ Health A</source> <year>2005</year>; <volume>68</volume>: <fpage>239</fpage>–<lpage>251</lpage>.</citation>
</ref>
<ref id="bibr12-0960327111422402">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Satoh</surname>
<given-names>K</given-names> </name>
<name>
<surname>Nagai</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Aoki</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Nishijima</surname>
<given-names>M.</given-names>
</name>
</person-group> <article-title>[Competitive binding of some alkyl p-hydroxybenzoates to human estrogen receptor alpha and beta]</article-title>. <source>Yakugaku Zasshi</source> <year>2000</year>; <volume>120</volume>: <fpage>1429</fpage>–<lpage>1433</lpage>.</citation>
</ref>
<ref id="bibr13-0960327111422402">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Darbre</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Byford</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Coldham</surname>
<given-names>NG</given-names>
</name>
<name>
<surname>Pope</surname>
<given-names>GS</given-names>
</name>
<etal/>
</person-group>. <article-title>Oestrogenic activity of benzylparaben</article-title>. <source>J Appl Toxicol</source> <year>2003</year>; <volume>23</volume>: <fpage>43</fpage>–<lpage>51</lpage>.</citation>
</ref>
<ref id="bibr14-0960327111422402">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Routledge</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Odum</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ashby</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sumpter</surname>
<given-names>JP</given-names>
</name>
</person-group>. <article-title>Some alkyl hydroxy benzoate preservatives (parabens) are estrogenic</article-title>. <source>Toxicol Appl Pharmacol</source> <year>1998</year>; <volume>153</volume>: <fpage>12</fpage>–<lpage>19</lpage>.</citation>
</ref>
<ref id="bibr15-0960327111422402">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Darbre</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Harvey</surname>
<given-names>PW</given-names>
</name>
</person-group>. <article-title>Paraben esters: review of recent studies of endocrine toxicity, absorption, esterase and human exposure, and discussion of potential human health risks</article-title>. <source>J Appl Toxicol</source> <year>2008</year>; <volume>28</volume>: <fpage>561</fpage>–<lpage>578</lpage>.</citation>
</ref>
<ref id="bibr16-0960327111422402">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Jeung</surname>
<given-names>EB</given-names>
</name>
</person-group>. <article-title>Molecular mechanism of regulation of the calcium-binding protein calbindin-D9k, and its physiological role(s) in mammals: a review of current research</article-title>. <source>J Cell Mol Med</source> <year>2008</year>; <volume>12</volume>: <fpage>409</fpage>–<lpage>420</lpage>.</citation>
</ref>
<ref id="bibr17-0960327111422402">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nguyen</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>YK</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>CK</given-names>
</name>
<name>
<surname>Jeung</surname>
<given-names>EB</given-names>
</name>
</person-group>. <article-title>A calcium binding protein, calbindin-D9k, is mainly regulated by estrogen in the pituitary gland of rats during estrous cycle</article-title>. <source>Brain Res Mol Brain Res</source> <year>2005</year>; <volume>141</volume>: <fpage>166</fpage>–<lpage>173</lpage>.</citation>
</ref>
<ref id="bibr18-0960327111422402">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tinnanooru</surname>
<given-names>P</given-names> </name>
<name>
<surname>Dang</surname>
<given-names>VH</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Jeung</surname>
<given-names>EB</given-names>
</name>
</person-group>. <article-title>Estrogen regulates the localization and expression of calbindin-D9k in the pituitary gland of immature male rats via the ERalpha-pathway</article-title>. <source>Mol Cell Endocrinol</source> <year>2008</year>; <volume>285</volume>: <fpage>26</fpage>–<lpage>33</lpage>.</citation>
</ref>
<ref id="bibr19-0960327111422402">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ben-Jonathan</surname>
<given-names>N</given-names> </name>
<name>
<surname>Chen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>, Dunckley</surname>
<given-names> JA</given-names>
</name>
<name>
<surname>, LaPensee</surname>
<given-names> C</given-names>
</name>
<name>
<surname> Kansra</surname>
<given-names>S.</given-names>
</name>
</person-group> <article-title>Estrogen receptor-alpha mediates the epidermal growth factor-stimulated prolactin expression and release in lactotrophs</article-title>. <source>Endocrinology</source> <year>2009</year>; <volume>150</volume>: <fpage>795</fpage>–<lpage>802</lpage>.</citation>
</ref>
<ref id="bibr20-0960327111422402">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dang</surname>
<given-names>VH</given-names> </name>
<name>
<surname>Nguyen</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Jeung</surname>
<given-names>EB.</given-names>
</name>
</person-group> <article-title>A calcium-binding protein, calbindin-D9k, is regulated through an estrogen-receptor mediated mechanism following xenoestrogen exposure in the GH3 cell line</article-title>. <source>Toxicol Sci</source> <year>2007</year>; <volume>98</volume>: <fpage>408</fpage>–<lpage>415</lpage>.</citation>
</ref>
<ref id="bibr21-0960327111422402">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>YW</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Jeung</surname>
<given-names>EB.</given-names>
</name>
</person-group> <article-title>Estrogen receptor alpha pathway is involved in the regulation of calbindin-D9k in the uterus of immature rats</article-title>. <source>Toxicol Sci</source> <year>2005</year>; <volume>84</volume>: <fpage>270</fpage>–<lpage>277</lpage>.</citation>
</ref>
<ref id="bibr22-0960327111422402">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taxvig</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Vinggaard</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Hass</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Axelstad</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Boberg</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>PR</given-names>
</name>
<etal/>
</person-group>. <article-title>Do parabens have the ability to interfere with steroidogenesis?</article-title> <source>Toxicol Sci</source> <year>2008</year>; <volume>106</volume>: <fpage>206</fpage>–<lpage>213</lpage>.</citation>
</ref>
<ref id="bibr23-0960327111422402">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soto</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Sonnenschein</surname>
<given-names>C</given-names>
</name>
</person-group>. <article-title>The pesticides endosulfan, toxaphene, and dieldrin have estrogenic effects on human estrogen-sensitive cells</article-title>. <source>Environ Health Perspect</source> <year>1994</year>; <volume>102</volume>: <fpage>380</fpage>–<lpage>383</lpage>.</citation>
</ref>
<ref id="bibr24-0960327111422402">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bergeron</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Crews</surname>
<given-names>D</given-names>
</name>
<name>
<surname>McLachlan</surname>
<given-names>JA</given-names>
</name>
</person-group>. <article-title>PCBs as environmental estrogens: turtle sex determination as a biomarker of environmental contamination</article-title>. <source>Environ Health Perspect</source> <year>1994</year>; <volume>102</volume>: <fpage>780</fpage>–<lpage>781</lpage>.</citation>
</ref>
<ref id="bibr25-0960327111422402">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silva</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Rajapakse</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kortenkamp</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Something from “nothing”—eight weak estrogenic chemicals combined at concentrations below NOECs produce significant mixture effects</article-title>. <source>Environ Sci Technol</source> <year>2002</year>; <volume>36</volume>: <fpage>1751</fpage>–<lpage>1756</lpage>.</citation>
</ref>
<ref id="bibr26-0960327111422402">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoo</surname>
<given-names>YM</given-names>
</name>
<name>
<surname>Jeung</surname>
<given-names>EB</given-names>
</name>
</person-group>. <article-title>Melatonin suppresses cyclosporine A-induced autophagy in rat pituitary GH3 cells</article-title>. <source>J Pineal Res </source>
<year>2010</year>; <volume>48</volume>: <fpage>204</fpage>–<lpage>211</lpage>.</citation>
</ref>
<ref id="bibr27-0960327111422402">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krisinger</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Setoyama</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Leung</surname>
<given-names>PC</given-names>
</name>
</person-group>. <article-title>Expression of calbindin-D9k in the early pregnant rat uterus: effects of RU 486 and correlation to estrogen receptor mRNA</article-title>. <source>Mol Cell Endocrinol</source> <year>1994</year>; <volume>102</volume>: <fpage>15</fpage>–<lpage>22</lpage>.</citation>
</ref>
<ref id="bibr28-0960327111422402">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krisinger</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dann</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Currie</surname>
<given-names>WD</given-names>
</name>
<name>
<surname>Jeung</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Leung</surname>
<given-names>PC</given-names>
</name>
</person-group>. <article-title>Calbindin-D9k mRNA is tightly regulated during the estrous cycle in the rat uterus</article-title>. <source>Mol Cell Endocrinol</source> <year>1992</year>; <volume>86</volume>: <fpage>119</fpage>–<lpage>123</lpage>.</citation>
</ref>
<ref id="bibr29-0960327111422402">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hong</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Jeung</surname>
<given-names>EB</given-names>
</name>
</person-group>. <article-title>Induction of calbindin-D9k messenger RNA and protein by maternal exposure to alkylphenols during late pregnancy in maternal and neonatal uteri of rats</article-title>. <source>Biol Reprod</source> <year>2004</year>; <volume>71</volume>: <fpage>669</fpage>–<lpage>675</lpage>.</citation>
</ref>
<ref id="bibr30-0960327111422402">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>An</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Jeung</surname>
<given-names>EB</given-names>
</name>
</person-group>. <article-title>Expression of human Calbindin-D(9k) correlated with age, vitamin D receptor and blood calcium level in the gastrointestinal tissues</article-title>. <source>Clin Biochem</source> <year>2003</year>; <volume>36</volume>: <fpage>255</fpage>–<lpage>261</lpage>.</citation>
</ref>
<ref id="bibr31-0960327111422402">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>An</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Jeung</surname>
<given-names>EB</given-names>
</name>
</person-group>. <article-title>Stimulation of calbindin-D(9k) mRNA expression in the rat uterus by octyl-phenol, nonylphenol and bisphenol</article-title>. <source>Mol Cell Endocrinol</source> <year>2002</year>; <volume>191</volume>: <fpage>177</fpage>–<lpage>186</lpage>.</citation>
</ref>
<ref id="bibr32-0960327111422402">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hossaini</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Larsen</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Larsen</surname>
<given-names>JC</given-names>
</name>
</person-group>. <article-title>Lack of oestrogenic effects of food preservatives (parabens) in uterotrophic assays</article-title>. <source>Food Chem Toxicol</source> <year>2000</year>; <volume>38</volume>: <fpage>319</fpage>–<lpage>323</lpage>.</citation>
</ref>
<ref id="bibr33-0960327111422402">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oishi</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>Effects of propyl paraben on the male reproductive system</article-title>. <source>Food Chem Toxicol</source> <year>2002</year>; <volume>40</volume>: <fpage>1807</fpage>–<lpage>1813</lpage>.</citation>
</ref>
<ref id="bibr34-0960327111422402">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soni</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Carabin</surname>
<given-names>IG</given-names>
</name>
<name>
<surname>Burdock</surname>
<given-names>GA</given-names>
</name>
</person-group>. <article-title>Safety assessment of esters of p-hydroxybenzoic acid (parabens)</article-title>. <source>Food Chem Toxicol</source> <year>2005</year>; <volume>43</volume>: <fpage>985</fpage>–<lpage>1015</lpage>.</citation>
</ref>
<ref id="bibr35-0960327111422402">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Soni</surname>
<given-names>MG</given-names> </name>
<name>
<surname>Taylor</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Greenberg</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Burdock</surname>
<given-names>GA</given-names>
</name>
</person-group>. <article-title>Evaluation of the health aspects of methyl paraben: a review of the published literature</article-title>. <source>Food Chem Toxicol</source> <year>2002</year>; <volume>40</volume>: <fpage>1335</fpage>–<lpage>1373</lpage>.</citation>
</ref>
<ref id="bibr36-0960327111422402">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>ZY</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>VC</given-names>
</name>
</person-group>. <article-title>Anti-estrogenic effect of unliganded progesterone receptor is estrogen-selective in breast cancer cells MCF-7</article-title>. <source>Cancer Lett</source> <year>2008</year>; <volume>268</volume>: <fpage>202</fpage>–<lpage>211</lpage>.</citation>
</ref>
<ref id="bibr37-0960327111422402">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Darbre</surname>
<given-names>PD</given-names> </name>
<name>
<surname>Aljarrah</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>WR</given-names>
</name>
<name>
<surname>Coldham</surname>
<given-names>NG</given-names>
</name>
<name>
<surname>Sauer</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Pope</surname>
<given-names>GS.</given-names>
</name>
</person-group> <article-title>Concentrations of parabens in human breast tumours</article-title>. <source>J Appl Toxicol</source> <year>2004</year>; <volume>24</volume>: <fpage>5</fpage>–<lpage>13</lpage>.</citation>
</ref>
<ref id="bibr38-0960327111422402">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tavares</surname>
<given-names>RS</given-names> </name>
<name>
<surname>Martins</surname>
<given-names>FC</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names> PJ</given-names>
</name>
<name>
<surname>Ramalho-Santos</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Peixoto</surname>
<given-names> FP</given-names>
</name>
</person-group>. <article-title>Parabens in male infertility-is there a mitochondrial connection?</article-title> <source>Reprod Toxicol</source> <year>2009</year>; <volume>27</volume>: <fpage>1</fpage>–<lpage>7</lpage>.</citation>
</ref>
<ref id="bibr39-0960327111422402">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Darbre</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Byford</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Horton</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Pope</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Sauer</surname>
<given-names>MJ</given-names>
</name>
</person-group>. <article-title>Oestrogenic activity of isobutylparaben in vitro and in vivo</article-title>. <source>J Appl Toxicol</source> <year>2002</year>; <volume>22</volume>: <fpage>219</fpage>–<lpage>226</lpage>.</citation>
</ref>
<ref id="bibr40-0960327111422402">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arnold</surname>
<given-names>SF</given-names> </name>
<name>
<surname>Bergeron</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names> DQ</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names> BM</given-names>
</name>
<name>
<surname>Vonier</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Crews</surname>
<given-names> D</given-names>
</name>
<etal/>
</person-group>. <article-title>Synergistic responses of steroidal estrogens in vitro (yeast) and in vivo (turtles)</article-title>. <source>Biochem Biophys Res Commun</source> <year>1997</year>; <volume>235</volume>: <fpage>336</fpage>–<lpage>342</lpage>.</citation>
</ref>
<ref id="bibr41-0960327111422402">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bigsby</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Nephew</surname>
<given-names>KP</given-names>
</name>
</person-group>. <article-title>The NEDD8 pathway is required for proteasome-mediated degradation of human estrogen receptor (ER)-alpha and essential for the antiproliferative activity of ICI 182,780 in ERalpha-positive breast cancer cells</article-title>. <source>Mol Endocrinol</source> <year>2003</year>; <volume>17</volume>: <fpage>356</fpage>–<lpage>365</lpage>.</citation>
</ref>
<ref id="bibr42-0960327111422402">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marsaud</surname>
<given-names>V</given-names> </name>
<name>
<surname>Gougelet</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Maillard</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Renoir</surname>
<given-names>JM</given-names>
</name>
</person-group>. <article-title>Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells</article-title>. <source>Mol Endocrinol</source> <year>2003</year>; <volume>17</volume>: <fpage>2013</fpage>–<lpage>2027</lpage>.</citation>
</ref>
<ref id="bibr43-0960327111422402">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oliveira</surname>
<given-names>CA</given-names> </name>
<name>
<surname>Nie</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Carnes</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Franca</surname>
<given-names>LR</given-names>
</name>
<name>
<surname>Prins</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Saunders</surname>
<given-names>PT</given-names>
</name>
<etal/>
</person-group>. <article-title>The antiestrogen ICI 182,780 decreases the expression of estrogen receptor-alpha but has no effect on estrogen receptor-beta and androgen receptor in rat efferent ductules</article-title>. <source>Reprod Biol Endocrinol</source> <year>2003</year>; <volume>1</volume>: <fpage>75</fpage>.</citation>
</ref>
<ref id="bibr44-0960327111422402">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dauvois</surname>
<given-names>S</given-names> </name>
<name>
<surname>Danielian</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>White</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>MG</given-names>
</name>
</person-group>. <article-title>Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover</article-title>. <source>Proc Natl Acad Sci U S A</source> <year>1992</year>; <volume>89</volume>: <fpage>4037</fpage>–<lpage>4041</lpage>.</citation>
</ref>
<ref id="bibr45-0960327111422402">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gibson</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Nemmers</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Beckman</surname>
<given-names>WC</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Davis</surname>
<given-names>VL</given-names>
</name>
<name>
<surname>Curtis</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Korach</surname>
<given-names>KS</given-names>
</name>
</person-group>. <article-title>The mechanism of ICI 164,384 antiestrogenicity involves rapid loss of estrogen receptor in uterine tissue</article-title>. <source>Endocrinology</source> <year>1991</year>; <volume>129</volume>: <fpage>2000</fpage>–<lpage>2010</lpage>.</citation>
</ref>
<ref id="bibr46-0960327111422402">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reese</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Katzenellenbogen</surname>
<given-names>BS</given-names>
</name>
</person-group>. <article-title>Examination of the DNA-binding ability of estrogen receptor in whole cells: implications for hormone-independent transactivation and the actions of antiestrogens</article-title>. <source>Mol Cell Biol</source> <year>1992</year>; <volume>12</volume>: <fpage>4531</fpage>–<lpage>4538</lpage>.</citation>
</ref>
<ref id="bibr47-0960327111422402">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robertson</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Semiglazov</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Nemsadze</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Dzagnidze</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Janjalia</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nicholson</surname>
<given-names>RI</given-names>
</name>
<etal/>
</person-group>. <article-title>Effects of fulvestrant 250 mg in premenopausal women with oestrogen receptor-positive primary breast cancer</article-title>. <source>Eur J Cancer</source> <year>2007</year>; <volume>43</volume>: <fpage>64</fpage>–<lpage>70</lpage>.</citation>
</ref>
<ref id="bibr48-0960327111422402">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinto</surname>
<given-names>PI</given-names> </name>
<name>
<surname>Singh</surname>
<given-names>PB</given-names>
</name>
<name>
<surname>Condeça</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Teodósio</surname>
<given-names>HR</given-names>
</name>
<name>
<surname>Power</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Canário</surname>
<given-names>AV</given-names>
</name>
</person-group>. <article-title>ICI 182,780 has agonistic effects and synergizes with estradiol-17 beta in fish liver, but not in testis</article-title>. <source>Reprod Biol Endocrinol</source> <year>2006</year>; <volume>4</volume>: <fpage>67</fpage>.</citation>
</ref>
<ref id="bibr49-0960327111422402">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>GS</given-names> </name>
<name>
<surname>Choi</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names> HJ</given-names>
</name>
<name>
<surname>Jeung</surname>
<given-names> EB</given-names>
</name>
</person-group>. <article-title>Effect of genistein as a selective estrogen receptor beta agonist on the expression of Calbindin-D9k in the uterus of immature rats</article-title>. <source>Toxicol Sci</source> <year>2004</year>; <volume>82</volume>: <fpage>451</fpage>–<lpage>457</lpage>.</citation>
</ref>
<ref id="bibr50-0960327111422402">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petz</surname>
<given-names>LN</given-names>
</name>
<name>
<surname>Ziegler</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Loven</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Nardulli</surname>
<given-names>AM</given-names>
</name>
</person-group>. <article-title>Estrogen receptor alpha and activating protein-1 mediate estrogen responsiveness of the progesterone receptor gene in MCF-7 breast cancer cells</article-title>. <source>Endocrinology</source> <year>2002</year>; <volume>143</volume>: <fpage>4583</fpage>–<lpage>4591</lpage>.</citation>
</ref>
<ref id="bibr51-0960327111422402">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blair</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Branham</surname>
<given-names>WS</given-names>
</name>
<name>
<surname>Hass</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Dial</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Moland</surname>
<given-names>CL</given-names>
</name>
<etal/>
</person-group>. <article-title>The estrogen receptor relative binding affinities of 188 natural and xenochemicals: structural diversity of ligands</article-title>. <source>Toxicol Sci</source> <year>2000</year>; <volume>54</volume>: <fpage>138</fpage>–<lpage>153</lpage>.</citation>
</ref>
<ref id="bibr52-0960327111422402">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nawaz</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Stancel</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Hyder</surname>
<given-names>SM</given-names>
</name>
</person-group>. <article-title>The pure antiestrogen ICI 182,780 inhibits progestin-induced transcription</article-title>. <source>Cancer Res</source> <year>1999</year>; <volume>59</volume>: <fpage>372</fpage>–<lpage>376</lpage>.</citation>
</ref>
<ref id="bibr53-0960327111422402">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vo</surname>
<given-names>TT</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>FH</given-names>
</name>
<name>
<surname>Jeung</surname>
<given-names>EB</given-names>
</name>
</person-group>. <article-title>Estrogen receptor alpha is involved in the induction of calbindin-D(9k) and progesterone receptor by parabens in GH3 cells: a biomarker gene for screening xenoestrogens</article-title>. <source>Steroids</source> <year>2011</year>; <volume>76</volume>: <fpage>675</fpage>–<lpage>681</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>